Agilent Technologies, Inc. (NYSE:A) Shares Sold by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. decreased its position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 3.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 117,952 shares of the medical research company's stock after selling 4,214 shares during the quarter. Robeco Institutional Asset Management B.V.'s holdings in Agilent Technologies were worth $17,514,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of A. Crewe Advisors LLC grew its stake in shares of Agilent Technologies by 114.8% in the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company's stock valued at $25,000 after buying an additional 101 shares in the last quarter. Livelsberger Financial Advisory bought a new position in Agilent Technologies in the 3rd quarter valued at about $28,000. Ridgewood Investments LLC acquired a new position in shares of Agilent Technologies during the 2nd quarter worth $29,000. Fortitude Family Office LLC raised its stake in shares of Agilent Technologies by 68.3% during the third quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company's stock valued at $35,000 after acquiring an additional 95 shares during the last quarter. Finally, Ashton Thomas Private Wealth LLC acquired a new stake in Agilent Technologies in the second quarter valued at $39,000. 87.42% of the stock is currently owned by institutional investors and hedge funds.

Agilent Technologies Trading Up 1.6 %

NYSE:A traded up $2.20 during midday trading on Thursday, hitting $139.98. 1,542,080 shares of the company traded hands, compared to its average volume of 1,684,410. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36. The firm's fifty day moving average is $139.64 and its 200-day moving average is $138.18. The firm has a market capitalization of $40.22 billion, a P/E ratio of 28.59, a P/E/G ratio of 6.02 and a beta of 1.07. Agilent Technologies, Inc. has a 12-month low of $104.09 and a 12-month high of $155.35.

Agilent Technologies (NYSE:A - Get Free Report) last released its earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share for the quarter, topping analysts' consensus estimates of $1.26 by $0.06. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.56 billion. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The business's revenue was down 5.6% compared to the same quarter last year. During the same quarter last year, the firm posted $1.43 earnings per share. On average, sell-side analysts predict that Agilent Technologies, Inc. will post 5.24 EPS for the current year.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st were paid a dividend of $0.236 per share. This represents a $0.94 annualized dividend and a dividend yield of 0.67%. The ex-dividend date was Tuesday, October 1st. Agilent Technologies's payout ratio is currently 19.50%.

Insider Activity at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total transaction of $283,910.00. Following the transaction, the chief executive officer now owns 24,118 shares in the company, valued at approximately $3,497,110. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of the firm's stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total transaction of $283,910.00. Following the completion of the sale, the chief executive officer now owns 24,118 shares of the company's stock, valued at $3,497,110. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Dominique Grau sold 9,990 shares of Agilent Technologies stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the sale, the senior vice president now owns 40,011 shares of the company's stock, valued at $5,801,595. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 11,995 shares of company stock worth $1,739,510 in the last 90 days. Corporate insiders own 0.33% of the company's stock.

Analyst Upgrades and Downgrades

A has been the subject of a number of research reports. Wells Fargo & Company initiated coverage on Agilent Technologies in a research note on Tuesday, August 27th. They issued an "overweight" rating and a $157.00 price objective for the company. Bank of America boosted their target price on shares of Agilent Technologies from $140.00 to $147.00 and gave the stock a "neutral" rating in a research report on Thursday, August 22nd. Evercore ISI boosted their price objective on Agilent Technologies from $135.00 to $145.00 and gave the stock an "in-line" rating in a report on Tuesday, October 1st. UBS Group raised their target price on Agilent Technologies from $141.00 to $150.00 and gave the company a "neutral" rating in a report on Thursday, August 22nd. Finally, Citigroup increased their price objective on shares of Agilent Technologies from $150.00 to $165.00 and gave the company a "buy" rating in a research note on Thursday, August 22nd. One analyst has rated the stock with a sell rating, five have given a hold rating and nine have assigned a buy rating to the company's stock. According to MarketBeat.com, Agilent Technologies currently has an average rating of "Moderate Buy" and a consensus target price of $144.36.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.